Endothelin-1 regulates proliferative responses, both alone and synergistically with PDGF, in rat tracheal smooth

Linda Yahiaoui1, Annie Villeneuve, Héctor Valderrama-Carvajal

  • 1Meakins-Christie Laboratories, Department of Medicine, McGill University, St. Urbain, Montreal, Quebec.

Insights

Endothelin-1 (ET-1) triggers airway smooth muscle cell proliferation via ET A receptors, involving ERK1/2 and Rho kinase pathways. This peptide also enhances PDGF-BB-stimulated proliferation, highlighting its role in airway remodeling.

Area of Science:

  • Cell Biology
  • Physiology
  • Pharmacology

Background:

  • Endothelin-1 (ET-1) is a peptide regulating cell proliferation.
  • Airway smooth muscle cell (SMC) proliferation contributes to airway remodeling in asthma.
  • ET-1 receptor antagonists have shown promise in preventing SMC proliferation in asthma models.

Purpose of the Study:

  • To identify signaling pathways regulating proliferative responses in cultured rat tracheal SMC.
  • To investigate the role of ET-1 and its receptor subtypes in SMC proliferation.
  • To elucidate the downstream signaling mechanisms activated by ET-1 in tracheal SMC.

Main Methods:

  • [(3)H]-thymidine incorporation assays were used to measure DNA synthesis.
  • Western immunoblotting was employed to detect protein activation.
  • Specific inhibitors like pertussis toxin and Rho kinase inhibitors were utilized.
  • Downregulation of protein kinase C (PKC) isoforms was performed.

Main Results:

  • ET-1 activation of the ET A receptor subtype stimulated [(3)H]-thymidine incorporation and ERK 1/2 activation in rat tracheal SMC.
  • ET-1-induced proliferation and ERK 1/2 activation were inhibited by pertussis toxin and PKC downregulation.
  • ET-1-induced [(3)H]-thymidine incorporation, but not ERK 1/2 activation, was abrogated by Rho kinase inhibition.
  • ET-1 potentiated platelet-derived growth factor-BB (PDGF-BB)-stimulated SMC proliferation and [(3)H]-thymidine incorporation, independent of ERK1/2.

Conclusions:

  • ET-1 induces proliferation of rat tracheal SMC through multiple signaling pathways.
  • ERK 1/2 and Rho kinase are key downstream mediators of ET-1-induced SMC proliferation.
  • ET-1's potentiation of PDGF-BB-stimulated proliferation suggests complex interactions in airway smooth muscle regulation.
  • These findings provide insights into the molecular mechanisms underlying airway smooth muscle remodeling.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...